Inventor · disambiguated record
Christoph Schliemann
Also filed as: SCHLIEMANN CHRISTOPH
4 granted patents·3 pending applications·7 citations·filing 2008–2017
67Inventor score
Top patents by PatentIndex Score
7 records- 0183US9446124B2Targeting of bone marrow neovasculaturePHILOGEN SPA·Filed 2014·Granted Sep 20, 2016·3 cites·7 claims
- 0280US8679488B2Targeting of bone marrow neovasculatureKASPAR MANUELA·Filed 2010·Granted Mar 25, 2014·4 cites·9 claims
- 0363US8796426B2Combination of an anti-EDb fibronectin antibody-IL-2 fusion protein, and a molecule binding to B cells, B cell progenitors and/or their cancerous counterpartNERI DARIO·Filed 2008·Granted Aug 5, 2014·0 cites·18 claims
- 0459US9289470B2Combination of an anti-EDb fibronectin antibody-IL-2 fusion protein, and a molecule binding to B cells, B cell progenitors and/or their cancerous counterpartPHILOGEN SPA·Filed 2014·Granted Mar 22, 2016·0 cites·29 claims
- 0559US2010310454A1Combination of an anti-edb fibronectin antibody-il-2 fusion protein, and a molecule binding to b cells, b cell progenitors and /or their cancerous counterpartNERI DARIO·Filed 2008·Application pending·0 cites
- 0647US2011318302A1Cancer TreatmentSCHWAGER KATHRIN·Filed 2009·Application pending·0 cites
- 0733US2019125840A1Combination therapy comprising an inflammatory immunocytokine and a chimeric antigen receptor (car)-t cellPHILOGEN SPA·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Christoph Schliemann files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →